Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Proteinuria × anlotinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 2 NSCLC 2 Thyroid Neoplasms 1 Sarcoma 1 Proteinuria 1 Platinum-resistant Ovarian Cancer (PROC) 1 Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

anlotinib 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07358520 2026-01-22

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

Fudan University

Phase 4 Not yet recruiting

Proteinuria

Data powered by HemOnc (CC BY 4.0) Colophon ⚡